{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:31:45Z","timestamp":1773009105885,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,19]]},"DOI":"10.7759\/cureus.18109","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T03:54:21Z","timestamp":1632110061000},"source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial"],"prefix":"10.7759","author":[{"given":"Shubhadeep","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenivasa","family":"Chary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leela","family":"Talluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam S","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagan M","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas V","family":"C. Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack J","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006, 130:1466-79. 10.1053\/j.gastro.2005.11.059","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini V","year":"2016","unstructured":"Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal disorders. Gastroenterology. 2016, 150:1380-92. 10.1053\/j.gastro.2016.02.011","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis","volume":"64","author":"Ford AC","year":"2015","unstructured":"Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015, 64:1049-57. 10.1136\/gutjnl-2014-307843","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12089.1","article-title":"The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?","volume":"6","author":"Corsetti M","year":"2017","unstructured":"Corsetti M, Fox M. The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?. F1000Res. 2017, 6:1778. 10.12688\/f1000research.12089.1","journal-title":"F1000Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30469-4","article-title":"Functional dyspepsia","volume":"396","author":"Ford AC","year":"2020","unstructured":"Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet. 2020, 396:1689-702. 10.1016\/S0140-6736(20)30469-4","journal-title":"Lancet"},{"key":"ref6","article-title":"Functional Dyspepsia","author":"Francis P","year":"2021","unstructured":"Francis P, Zavala SR. Functional Dyspepsia. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.640576","article-title":"Rikkunshito as a therapeutic agent for functional dyspepsia and its prokinetic and non-prokinetic effects","volume":"12","author":"Inokuchi K","year":"2021","unstructured":"Inokuchi K, Masaoka T, Kanai T. Rikkunshito as a therapeutic agent for functional dyspepsia and its prokinetic and non-prokinetic effects. Front Pharmacol. 2021, 12:640576. 10.3389\/fphar.2021.640576","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2013.19.4.495","article-title":"Effects of the addition of mosapride to gastroesophageal reflux disease patients on proton pump inhibitor: a prospective randomized, double-blind study","volume":"19","author":"Lim HC","year":"2013","unstructured":"Lim HC, Kim JH, Youn YH, Lee EH, Lee BK, Park H. Effects of the addition of mosapride to gastroesophageal reflux disease patients on proton pump inhibitor: a prospective randomized, double-blind study. J Neurogastroenterol Motil. 2013, 19:495-502. 10.5056\/jnm.2013.19.4.495","journal-title":"J Neurogastroenterol Motil"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1994.266.2.G230","article-title":"5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons","volume":"266","author":"Pan H","year":"1994","unstructured":"Pan H, Galligan JJ. 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol. 1994, 266:G230-8. 10.1152\/ajpgi.1994.266.2.G230","journal-title":"Am J Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(89)80012-5","article-title":"Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum","volume":"96","author":"Tonini M","year":"1989","unstructured":"Tonini M, Galligan JJ, North RA. Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology. 1989, 96:1257-64. 10.1016\/s0016-5085(89)80012-5","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01180.x","article-title":"Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia","volume":"16","author":"Distrutti E","year":"2002","unstructured":"Distrutti E, Fiorucci S, Hauer SK, Pensi MO, Vanasia M, Morelli A. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther. 2002, 16:613-22. 10.1046\/j.1365-2036.2002.01180.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.562890","article-title":"Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia","volume":"20","author":"Tack J","year":"2011","unstructured":"Tack J, Janssen P. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. Expert Opin Investig Drugs. 2011, 20:701-12. 10.1517\/13543784.2011.562890","journal-title":"Expert Opin Investig Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13284","article-title":"Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial","volume":"30","author":"Tack J","year":"2018","unstructured":"Tack J, Pokrotnieks J, Urbonas G, et al.. Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial. Neurogastroenterol Motil. 2018, 30:e13284. 10.1111\/nmo.13284","journal-title":"Neurogastroenterol Motil"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02774.x","article-title":"Validation of a 7-point global overall symptom scale to measure the severity of dyspepsia symptoms in clinical trials","volume":"23","author":"Veldhuyzen van Zanten SJ","year":"2006","unstructured":"Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, et al.. Validation of a 7-point global overall symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ther. 2006, 23:521-9. 10.1111\/j.1365-2036.2006.02774.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00900.x","article-title":"Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form","volume":"15","author":"Talley NJ","year":"2001","unstructured":"Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001, 15:207-16. 10.1046\/j.1365-2036.2001.00900.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.003","article-title":"Functional dyspepsia impacts absenteeism and direct and indirect costs","volume":"8","author":"Brook RA","year":"2010","unstructured":"Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010, 8:498-503. 10.1016\/j.cgh.2010.03.003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","article-title":"Functional dyspepsia: a review of the symptoms, evaluation, and treatment options","volume":"16","author":"Harer KN","year":"2020","unstructured":"Harer KN, Hasler WL. Functional dyspepsia: a review of the symptoms, evaluation, and treatment options. Gastroenterol Hepatol (N Y). 2020, 16:66-74.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-020-01106-y","article-title":"Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India","volume":"40","author":"Goyal O","year":"2021","unstructured":"Goyal O, Nohria S, Dhaliwal AS, Goyal P, Soni RK, Chhina RS, Sood A. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India. Indian J Gastroenterol. 2021, 40:144-53. 10.1007\/s12664-020-01106-y","journal-title":"Indian J Gastroenterol"},{"key":"ref19","article-title":"Proton Pump Inhibitors (PPI)","author":"Ahmed A","year":"2021","unstructured":"Ahmed A, Clarke JO. Proton Pump Inhibitors (PPI). StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report","volume":"154","author":"Drossman DA","year":"2018","unstructured":"Drossman DA, Tack J, Ford AC, Szigethy E, T\u00f6rnblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report. Gastroenterology. 2018, 154:1140-1171. 10.1053\/j.gastro.2017.11.279","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009431.pub3","article-title":"Prokinetics for functional dyspepsia","volume":"10","author":"Pittayanon R","year":"2018","unstructured":"Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Leontiadis GI, Moayyedi P. Prokinetics for functional dyspepsia. Cochrane Database Syst Rev. 2018, 10:CD009431. 10.1002\/14651858.CD009431.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000358111","article-title":"Therapeutic options for functional dyspepsia","volume":"32","author":"Vanheel H","year":"2014","unstructured":"Vanheel H, Tack J. Therapeutic options for functional dyspepsia. Dig Dis. 2014, 32:230-4. 10.1159\/000358111","journal-title":"Dig Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01449.x","article-title":"Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage","volume":"22","author":"Matsueda K","year":"2010","unstructured":"Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil. 2010, 22:618-e173. 10.1111\/j.1365-2982.2009.01449.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01261.x","article-title":"A dose-ranging, placebo-controlled, pilot trial of acotiamide in patients with functional dyspepsia","volume":"21","author":"Tack J","year":"2009","unstructured":"Tack J, Masclee A, Heading R, et al.. A dose-ranging, placebo-controlled, pilot trial of acotiamide in patients with functional dyspepsia. Neurogastroenterol Motil. 2009, 21:272-80. 10.1111\/j.1365-2982.2009.01261.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref25","article-title":"Efficacy and safety assessment of acotiamide and Levosulpiride in functional dyspepsia","volume":"16","author":"Behera R","year":"2017","unstructured":"Behera R, Sethi S. Efficacy and safety assessment of acotiamide and Levosulpiride in functional dyspepsia. J Dent Med Sci. 2017, 16:53-57.","journal-title":"J Dent Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4172\/2161-069X.1000553","article-title":"Real world efficacy and tolerability of acotiamide, in relieving meal-related symptoms of functional dyspepsia","volume":"8","author":"Narayanan V","year":"2018","unstructured":"Narayanan V, Bhargava A, Pallewar S. Real world efficacy and tolerability of acotiamide, in relieving meal-related symptoms of functional dyspepsia. J Gastrointest Dig Syst. 2018, 8:553. 10.4172\/2161-069X.1000553","journal-title":"J Gastrointest Dig Syst"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301454","article-title":"A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia","volume":"61","author":"Matsueda K","year":"2012","unstructured":"Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012, 61:821-8. 10.1136\/gutjnl-2011-301454","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16072","article-title":"Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia","volume":"53","author":"Ford AC","year":"2021","unstructured":"Ford AC, Moayyedi P, Black CJ, et al.. Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia. Aliment Pharmacol Ther. 2021, 53:8-21. 10.1111\/apt.16072","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67520-efficacy-and-safety-of-acotiamide-versus-mosapride-in-patients-with-functional-dyspepsia-associated-with-meal-induced-postprandial-distress-syndrome-a-phase-iii-randomized-clinical-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:17Z","timestamp":1707507017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67520-efficacy-and-safety-of-acotiamide-versus-mosapride-in-patients-with-functional-dyspepsia-associated-with-meal-induced-postprandial-distress-syndrome-a-phase-iii-randomized-clinical-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,19]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.18109","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,19]]}}}